“…MCDA methods were also used to help decision makers with criteria assessments for setting priorities ( n = 4), to support HTA decision‐making processes ( n = 14) and regulatory decisions during pandemic influenza (Maro, Fryback, Lieu, Lee, & Martin, ), as well as to assess care quality ( n = 6), select new medical equipment ( n = 6), compare methods for suitability ( n = 3), assess screening priorities (Dolan, Boohaker, Allison, & Imperiale, ), define new fee schedules (Hung, Huang, & Chang, ), assess potential harms (Nutt, King, & Phillips, ), improve outpatient services (Kuo, Wu, & Hsu, ), support early diagnosis (Nunes, Pinheiro, Pequeno, & Pinheiro, ), select healthcare waste‐treatment technologies (Lu, You, Liu, & Li, ), select an infrastructure's localization (Vahidnia, Alesheikh, & Alimohammadi, ), optimize a process (Bennis, Janah, & Benajiba, ), and evaluate the performance of medical devices (Lee, Chung, & Shyu, ).…”